Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Ikaria’s Hybrid Business Model Taps Big Pharma Trends

May 23 2012

Related Content

Advanced BioHealing To Bring Regeneration To Shire

May 23 2011

Covidien Pure-Play: Pharma Spin-Off Now Officially In The Works

Dec 15 2011

With Second Licensing Deal In A Month, Ikaria Adds To Critical Care Pipeline

Aug 11 2009

Personalizing Patient Care:Sanofi Recasts Its Diabetes Efforts

Jul 01 2010

The Shake Up At Endo Pharma

Jul 01 2010

Ikaria, NuPathe File Initial Public Offerings

May 14 2010

Follow The CEO? Abbott Chief Chooses Diversified Products, Emerging Markets Over Rx Drugs As Company Splits In Two

Oct 20 2011

Moving Beyond <em>Cubicin</em>: Cubist Sets The Stage For Long-Term Growth

May 23 2012

The Abbott Split Up: Who Wins?

Oct 24 2011

Biopharmaceuticals Beyond The Drug: Changing Pharma's Value Proposition

Oct 01 2011

Ikaria Backers Buy INO, Create Model for Self-Funding Discovery

Mar 01 2007

Ikaria Inc.

Jun 01 2005

Related Companies

Ikaria Holdings, Inc.

Fred Hutchinson Cancer Research Center

GSK plc

National Institutes of Health

Orphan Therapeutics, LLC

Ferring Pharmaceuticals

Pfizer Inc.

Eli Lilly and Company

Actelion Pharmaceuticals Ltd.

United Therapeutics Corporation

Abbott

Covidien plc

Johnson & Johnson

Sanofi

Additional Topics

Strategy Clinical Trials Innovation BioPharmaceutical Combination Products

More from Innovation

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window